Jean‐Jacques Stelmes

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux et al. · The Lancet Oncology · 2020 · 446 citations · Full text

Surgical Oncology, Primary Retroperitoneal Sarcoma, Radiation Therapy +7

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

Damien C. Weber, C. Ares, S. Villà et al. · Radiotherapy and Oncology · 2018 · 172 citations · Full text

Neuro-oncology, Surgical Oncology, Radiation Therapy +10

Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors

Denis Maillet, Pauline Corbaux, Jean‐Jacques Stelmes et al. · European Journal of Cancer · 2020 · 69 citations

Autoimmune Disease, Medicine, Immune Checkpoint Inhibitors +11

Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial

Jean‐Jacques Stelmes, Vincent Grégoire, Vincent Vander Poorten et al. · Frontiers in Oncology · 2019 · 36 citations · Full text

Surgical Oncology, Late Functional Outcome, Cancer Management +19

Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092‐22092 STRASS trial

Rick L. Haas, Jean‐Jacques Stelmes, Facundo Zaffaroni et al. · Cancer · 2022 · 30 citations · Full text